OMCL
Omnicell Inc
NASDAQ · Health Care
$37.07
-2.01 (-5.14%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 1.15B | 1.18B | 1.71B | 1.69B | 1.69B |
| Net Income | 1.99M | 1.84M | 83.18M | 82.52M | 97.89M |
| EPS | — | — | — | — | — |
| Profit Margin | 0.2% | 0.2% | 4.9% | 4.9% | 5.8% |
| Rev Growth | -2.9% | -2.9% | -7.8% | -3.3% | +5.9% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 99.64M | 99.64M | 640.58M | 510.00M | 606.53M |
| Total Equity | 732.14M | 732.14M | 633.58M | 603.03M | 581.87M |
| D/E Ratio | 0.14 | 0.14 | 1.01 | 0.85 | 1.04 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 81.27M | 79.54M | 142.45M | 161.95M | 137.80M |
| Free Cash Flow | — | — | 71.68M | 61.22M | 53.55M |